Back to Search
Start Over
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
- Source :
- Nature Medicine. February 2017, Vol. 23 Issue 2, p256, 8 p.
- Publication Year :
- 2017
-
Abstract
- Author(s): Nikolas Herold (corresponding author) [1]; Sean G Rudd [2]; Linda Ljungblad [1]; Kumar Sanjiv [2]; Ida Hed Myrberg [1]; Cynthia B J Paulin [2]; Yaser Heshmati [3]; Anna Hagenkort [...]
- Subjects :
- Care and treatment
Innovations
Development and progression
Genetic aspects
Patient outcomes
Health aspects
Drug interactions -- Genetic aspects
Cellular proteins -- Health aspects
Cytarabine -- Patient outcomes
Molecular targeted therapy -- Innovations
Hematologic diseases -- Genetic aspects -- Development and progression -- Care and treatment
Subjects
Details
- Language :
- English
- ISSN :
- 10788956
- Volume :
- 23
- Issue :
- 2
- Database :
- Gale General OneFile
- Journal :
- Nature Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.488764325
- Full Text :
- https://doi.org/10.1038/nm.4265